48,830
edits
Difference between revisions of "Choriocarcinoma"
Jump to navigation
Jump to search
→IHC
m (touch) |
(→IHC) |
||
| Line 94: | Line 94: | ||
[[ISUP]] consensus paper by Ulbright ''et al.'':<ref name=pmid24832161>{{cite journal |author=Ulbright TM, Tickoo SK, Berney DM, Srigley JR |title=Best practices recommendations in the application of immunohistochemistry in testicular tumors: report from the international society of urological pathology consensus conference |journal=Am. J. Surg. Pathol. |volume=38 |issue=8 |pages=e50–9 |year=2014 |month=August |pmid=24832161 |doi=10.1097/PAS.0000000000000233 |url=}}</ref> | [[ISUP]] consensus paper by Ulbright ''et al.'':<ref name=pmid24832161>{{cite journal |author=Ulbright TM, Tickoo SK, Berney DM, Srigley JR |title=Best practices recommendations in the application of immunohistochemistry in testicular tumors: report from the international society of urological pathology consensus conference |journal=Am. J. Surg. Pathol. |volume=38 |issue=8 |pages=e50–9 |year=2014 |month=August |pmid=24832161 |doi=10.1097/PAS.0000000000000233 |url=}}</ref> | ||
*Beta-hCG +ve. | *Beta-hCG +ve. | ||
*Glypican 3 +ve/-ve. | *[[Glypican 3]] +ve/-ve. | ||
*OCT3 -ve. | *OCT3 -ve. | ||
*AFP -ve. | *AFP -ve. | ||